SCT200
Product Specifications
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, Angiogenesis, JAK/STAT signaling
Bioactivity
SCT200 is a fully humanized IgG1 monoclonal antibody targeting EGFR, with a Kd value of 0.08 nM. It can eliminate tumor cells via complement-dependent cytotoxicity (CDC) and antibody-dependent cellular cytotoxicity (ADCC) through its Fc fragment. SCT200 is utilized in research on refractory RAS and BRAF wild-type metastatic colorectal cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
